Estados financieros detallados de Cingulate Inc. (CING): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $5.09, CING presenta beneficios negativos (P/E no significativo) y un ROE del -8.95%. La capitalización bursátil es de $69M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $178912 | $842353 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$178912 | -$842353 | 0 | 0 | 0 | 0 | 0 |
| I+D | $9.1M | $5.1M | $8.4M | $9.0M | $15.5M | $9.4M | $9.8M |
| Generales y Administrativos | $2.4M | $1.1M | $12.3M | $8.5M | $7.3M | $6.2M | $10.2M |
| Gastos Operativos | $11.5M | $6.2M | $20.7M | $17.5M | $22.8M | $15.6M | $19.9M |
| Beneficio Operativo | -$11.6M | -$7.1M | -$20.7M | -$17.5M | -$22.8M | -$15.6M | -$19.9M |
| EBITDA | -$11.5M | -$6.2M | -$20.0M | -$17.1M | -$22.2M | -$15.0M | -$19.4M |
| Gastos por Intereses | 0 | $54605 | $33407 | $174000 | 0 | 0 | $924446 |
| Beneficio Antes de Impuestos | -$11.5M | -$7.2M | -$20.7M | -$17.7M | -$23.5M | -$16.6M | -$22.4M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$11.5M | -$7.2M | -$20.7M | -$17.7M | -$23.5M | -$16.6M | -$22.4M |
| BPA | $-242.89 | $-12.70 | $-55.80 | $-31.20 | $-311.99 | $-10.20 | $-4.13 |
| BPA Diluido | $-242.89 | $-12.70 | $-55.80 | $-31.20 | $-311.99 | $-10.20 | $-4.13 |
| Acciones en Circulación (Diluidas) | $1.4M | $1.4M | $1.4M | $1.4M | $2.3M | $3.8M | $5.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$6.0M | -$5.6M | -$7.9M | -$5.4M |
| EBITDA | -$5.9M | -$5.5M | -$7.8M | $213.6M |
| Beneficio Neto | -$7.3M | -$6.3M | -$9.3M | -$5.9M |
| BPA | $-1.35 | $-0.87 | $-1.71 | $-1.08 |
| BPA Diluido | $-1.35 | $-0.87 | $-1.71 | $-1.08 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $418470 | $1.2M | $16.5M | $5.4M | $52416 | $12.2M | $11.0M |
| Inversiones a Corto | $18723 | $933 | $933 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $113240 | $151772 | 0 | $234432 | $14622 | $26325 | $8013 |
| Inventario | 0 | 0 | 0 | $100339 | 0 | 0 | 0 |
| Activos Corrientes | $978317 | $1.8M | $18.9M | $7.9M | $578594 | $12.7M | $12.0M |
| Inmovilizado Material | $4.2M | $4.0M | $4.0M | $3.5M | $2.9M | $2.2M | $3.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $5.3M | $5.8M | $22.9M | $11.4M | $3.5M | $14.9M | $15.1M |
| Cuentas por Pagar | $1.9M | $975114 | $264687 | $762357 | $5.2M | $1.3M | $2.0M |
| Deuda a Corto | 0 | $500335 | 0 | $5.0M | $3.0M | $2.5M | $6.3M |
| Pasivos Corrientes | $3.0M | $3.4M | $1.2M | $7.0M | $10.2M | $5.0M | $10.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $2.4M | $1.2M |
| Pasivos Totales | $4.7M | $4.5M | $2.0M | $7.5M | $10.4M | $7.4M | $12.6M |
| Reservas | 0 | -$31.0M | -$51.7M | -$69.4M | -$92.9M | -$108.5M | -$132.4M |
| Patrimonio Neto | $615880 | $1.3M | $20.8M | $3.9M | -$6.9M | $7.5M | $2.5M |
| Deuda Total | $2.1M | $2.0M | $1.2M | $5.9M | $3.5M | $5.1M | $8.8M |
| Deuda Neta | $1.7M | $848060 | -$15.3M | $509767 | $3.5M | -$7.1M | -$2.2M |
| Capital Circulante | -$2.0M | -$1.6M | $17.7M | $856852 | -$9.6M | $7.7M | $1.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $6.1M | $11.0M | $25.9M | $28.4M |
| Activos Totales | $10.5M | $15.1M | $30.9M | $33.1M |
| Pasivos Totales | $7.0M | $12.6M | $12.0M | $9.6M |
| Patrimonio Neto | $3.5M | $2.5M | $18.9M | $23.5M |
| Deuda Total | $4.6M | $8.8M | $7.4M | $6.3M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$11.5M | -$7.2M | -$20.7M | -$17.7M | -$23.5M | -$15.5M | -$22.4M |
| Amortizaciones | $178912 | $666029 | $708317 | $394011 | $582918 | $653090 | $540894 |
| Compensación en Acciones | 0 | 0 | $12.8M | $800796 | $812670 | $995484 | 0 |
| Cambio en Capital Circulante | $1.9M | -$293493 | -$3.2M | $598617 | $7.1M | -$4.6M | $830852 |
| Flujo de Caja Operativo | -$9.5M | -$6.8M | -$10.4M | -$15.9M | -$15.0M | -$18.5M | -$17.2M |
| Inversiones (CapEx) | -$1.0M | -$402096 | -$814736 | -$153420 | -$224096 | -$211800 | -$162138 |
| Adquisiciones | -$3.8M | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$10.5M | -$7.2M | -$11.2M | -$16.0M | -$15.3M | -$18.7M | -$17.4M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$4.2M | -$3.6M | -$6.9M | -$5.9M |
| Inversiones (CapEx) | $4 | -$156213 | -$61180 | -$67075 |
| Flujo de Caja Libre | -$4.2M | -$3.8M | -$7.0M | -$6.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $592824 | $385965 | $593100 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | +37.8% | -188.3% | +14.6% | -33.1% | +29.6% | -35.6% |
| Crecimiento BPA (anual) | | +94.8% | -339.4% | +44.1% | -900.0% | +96.7% | +59.5% |
| Cambio en Acciones (anual) | | +0.0% | +0.0% | +0.0% | +60.1% | +68.4% | +42.5% |
| Crecimiento FCF (anual) | | +31.6% | -55.9% | -42.6% | +4.8% | -22.3% | +6.7% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-7.46 | $-5.10 | $-7.96 | $-11.34 | $-6.74 | $-4.90 | $-3.21 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.4M | $1.4M | $1.4M | $1.4M | $2.3M | $3.8M | $5.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -894.81% |
| Rentabilidad sobre capital invertido | -176.51% |
| Rentabilidad sobre activos | -148.94% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.27 |
| Ratio corriente | 3.50 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -4.40 | -84.09 | -11.87 | -7.69 | -0.29 | -0.48 | -1.05 |
| P/VC | 2451.43 | 1168.17 | 44.93 | 87.40 | -30.24 | 2.52 | 9.40 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |